{
    "id": "bowtie_mag_education_v2026_47",
    "type": "bowtie",
    "stem": "A 25-year-old client is being started on a loading dose of Magnesium Sulfate for preeclampsia. Based on the documentation in the Magnesium Infusion Narrative & Patient Education tab, complete the bowtie by selecting the most likely condition, the two actions the nurse should take, and the two parameters the nurse should monitor.",
    "itemContext": {
        "tabs": [
            {
                "id": "sbar",
                "title": "SBAR",
                "content": "<b>Situation:</b> Initiation of magnesium seizure prophylaxis for preeclampsia with severe features.<br><b>Background:</b> The client is a 25-year-old female receiving a 4g loading dose of Magnesium Sulfate, initiated at 14:00.<br><b>Assessment:</b> At 14:15, the client reports, 'I feel like I'm on fire inside, my face is so hot, and I'm a little drowsy.' Vital signs are stable: BP 148/92, HR 82, RR 16, T 99.1°F, SpO2 99%. Deep tendon reflexes are 2+.<br><b>Recommendation:</b> Continue to monitor vital signs, deep tendon reflexes, and assess for any signs of magnesium toxicity. Reassure the client regarding expected side effects."
            },
            {
                "id": "narrative",
                "title": "Magnesium Infusion & Education",
                "content": "<table><thead><tr><th>Assessment Item</th><th>Finding</th><th>Significance</th></tr></thead><tbody><tr><td>Flush Response</td><td>Visible facial flushing and sweating</td><td>Expected (Vasodilation)</td></tr><tr><td>Deep Tendon Reflexes</td><td>2+ (Active and equal)</td><td>Normal / Therapeutic</td></tr><tr><td>Respirations</td><td>16 bpm (Even/Unlabored)</td><td>Normal</td></tr><tr><td>Serum Mag Level</td><td>5.2 mEq/L (In-range)</td><td>Therapeutic (4.0–7.0)</td></tr></tbody></table>"
            },
            {
                "id": "vitals",
                "title": "Vital Signs",
                "content": "BP 148/92, HR 82, RR 16, T 99.1°F. SpO2 99%."
            },
            {
                "id": "labs",
                "title": "Labs",
                "content": "Serum Magnesium: 5.2 mEq/L"
            }
        ]
    },
    "bowtieData": {
        "conditionOptions": [
            {
                "id": "c1",
                "text": "Magnesium Toxicity (Incipient Phase)"
            },
            {
                "id": "c2",
                "text": "Therapeutic Magnesium Effect (Expected Response)"
            },
            {
                "id": "c3",
                "text": "Anaphylactic Reaction to Magnesium"
            }
        ],
        "actionOptions": [
            {
                "id": "a1",
                "text": "Reassure the client that 'flushing' and 'warmth' are expected side effects."
            },
            {
                "id": "a2",
                "text": "Continue the Magnesium Sulfate infusion at the prescribed maintenance rate."
            },
            {
                "id": "a3",
                "text": "Immediately stop the infusion and call for the medical emergency team."
            },
            {
                "id": "a4",
                "text": "Administer STAT IV Calcium Gluconate."
            }
        ],
        "parameterOptions": [
            {
                "id": "p1",
                "text": "Continuous monitoring of respiratory rate and effort."
            },
            {
                "id": "p2",
                "text": "Deep Tendon Reflexes (DTRs) assessed hourly."
            },
            {
                "id": "p3",
                "text": "Daily measurement of fasting serum glucose."
            },
            {
                "id": "p4",
                "text": "Presence of a positive Babinski sign."
            }
        ]
    },
    "correctAnswers": {
        "condition": "c2",
        "actions": [
            "a1",
            "a2"
        ],
        "parameters": [
            "p1",
            "p2"
        ]
    },
    "pedagogy": {
        "bloomLevel": "analyze",
        "cjmmStep": "takeAction",
        "nclexCategory": "Pharmacological and Parenteral Therapies",
        "difficulty": 3,
        "topicTags": [
            "Magnesium Sulfate",
            "Preeclampsia",
            "Patient Education"
        ]
    },
    "rationale": {
        "correct": "The client is experiencing the Therapeutic Effect of Magnesium Sulfate (c2). During a loading dose (4g over 20-30 mins), rapid vasodilation causes an intense sensation of 'flushing' or 'burning' and mild drowsiness. Since the reflexes are still 2+ (Normal) and the RR is 16 (Normal), there is no toxicity. The nurse should reassure the client (a1) and continue the medication as prescribed (a2). Constant monitoring of RR (p1) and DTRs (p2) is the standard of care for magnesium therapy to detect early signs of toxicity.",
        "clinicalPearls": [
            "Therapeutic Mag range for preeclampsia: 4.0–7.0 mEq/L.",
            "The FIRST sign of toxicity is the LOSS of deep tendon reflexes (Magnesium blocks neuromuscular transmission).",
            "Magnesium is primarily cleared by kidneys; oliguria (< 30mL/hr) is a major risk factor for toxicity."
        ],
        "questionTrap": {
            "trap": "Stopping the drug because the patient says they feel 'burning' or 'hot'.",
            "howToOvercome": "Flushing is NOT toxicity. It is an expected side effect of the high-dose magnesium. If the reflexes are present and the breathing is fine, the drug is safe."
        },
        "mnemonic": {
            "title": "Mag Warmth",
            "expansion": "Feel the flush, there's no rush; if the reflexes say OK, then let it stay."
        }
    },
    "scoring": {
        "method": "polytomous",
        "maxPoints": 5
    },
    "sentinelStatus": "deep_healed_v2026"
}